Coloplast's Johanne Louis-Hansen dies
Johanne Louis-Hansen, co-founder of Coloplast, dies.
View ArticleThird quarter results
During the first 9 months of the financial year 2009/10 Coloplast delivered organic growth of 7%, and a profit margin of 20% against 15% last year.
View ArticleColoplast delivers 9M result in line with guidance
Revenue grew by 7% organically to DKK 10,942 million in the 9M 2015/16 period. EBIT was up by 8% to DKK 3,562 million for an EBIT margin of 33%. The results are in line with expectations.
View ArticleColoplast delivers 8% growth and upgrades full-year growth guidance
Coloplast delivered 8% organic revenue growth and an EBIT margin of 31% at constant exchange rates in the third quarter of the 2017/18 financial year. This is the fifth quarter running of 8% revenue...
View ArticleContinued earnings improvement, however, pressure on European growth
In the first quarter of 2011/12 revenue increased by 4% to DKK 2,654m and the EBIT margin was 26% against 24% in the same period of last year.
View ArticleColoplast acquires Nine Continents Medical, Inc.
Coloplast announced today that it has completed the acquisition of Nine Continents Medical, Inc., an early stage company pioneering an implantable tibial nerve stimulation treatment for over-active...
View ArticleNorth American headquarters
St. Paul - Governor Tim Pawlenty announced today that Coloplast will move its North American corporate headquarters to Minnesota beginning this fall.
View ArticleColoplast acquires SAS Lilial
Today Coloplast A/S acquires the French direct-to-consumer home delivery company SAS Lilial (Lilial) for a cash consideration of EUR 35.5m equal to approx. DKK 264m.
View Article
